再灌注ST段抬高型心肌梗死患者初始左心室重构的预后价值
纳入498例症状发作6小时内接受经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者,住院期间和6个月后行心脏磁共振检查,确定左心室不良重构的最佳定义以预测主要终点,并评估其是否在早期心脏磁共振基础上增加预后信息。结果显示左心室舒张末期容积相对增加15%和左心室射血分数相对下降3%是最佳阈值,但6个月时评估左心室不良重构未能改善早期心脏磁共振提供的预测信息。
要点
- 左心室舒张末期容积相对增加15%与主要终点风险相关(HR 2.1,p=0.007)。
- 左心室射血分数相对下降3%与主要终点风险相关(HR 2.5,p=0.001)。
- 6个月时评估左心室不良重构未在早期心脏磁共振基础上增加预后信息(C统计量0.723 vs 0.795)。
核心结论
- 预测不良心血管事件的最佳左心室不良重构定义应同时考虑左心室舒张末期容积增加和左心室射血分数下降,但评估左心室不良重构并未改善早期心脏磁共振提供的信息。
研究设计与样本
- 研究纳入498例症状发作6小时内接受经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者,住院期间(6.2±2.6天)和6个月后(6.1±1.8个月)行心脏磁共振检查,确定与主要终点相关的左心室舒张末期容积增加和左心室射血分数下降的最佳阈值,主要终点为心血管死亡、心力衰竭住院或室性心律失常的复合终点。
诊断标准与关键数值
- 左心室舒张末期容积相对增加15%对应主要终点风险HR 2.1(p=0.007),左心室射血分数相对下降3%对应HR 2.5(p=0.001)。
临床应用与阅片要点
- 早期心脏磁共振已能提供预后信息,6个月时评估左心室不良重构未显示额外预测价值。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study sought to establish the best definition of left ventricular adverse remodeling (LVAR) to predict outcomes and determine whether its assessment adds prognostic information to that obtained by early cardiac magnetic resonance (CMR).
BACKGROUND: LVAR, usually defined as an increase in left ventricular end-diastolic volume (LVEDV) is the main cause of heart failure after an ST-segment elevated myocardial infarction; however, the role of assessment of LVAR in predicting cardiovascular events remains controversial.
METHODS: Patients with ST-segment elevated myocardial infarction who received percutaneous coronary intervention within 6 h of symptom onset were included (n = 498). CMR was performed during hospitalization (6.2 ± 2.6 days) and after 6 months (6.1 ± 1.8 months). The optimal threshold values of the LVEDV increase and the LV ejection fraction decrease associated with the primary endpoint were ascertained. Primary outcome was a composite of cardiovascular mortality, hospitalization for heart failure, or ventricular arrhythmia.
RESULTS: The study was completed by 374 patients. Forty-nine patients presented the primary endpoint during follow-up (72.9 ± 42.8 months). Values that maximized the ability to identify patients with and without outcomes were a relative rise in LVEDV of 15% (hazard ratio [HR]: 2.1; p = 0.007) and a relative fall in LV ejection fraction of 3% (HR: 2.5; p = 0.001). However, the predictive model (using C-statistic analysis) failed to demonstrate that direct observation of LVAR at 6 months adds information to data from early CMR in predicting outcomes (C-statistic: 0.723 vs. 0.795).
CONCLUSIONS: The definition of LVAR that best predicts adverse cardiovascular events should consider both the increase in LVEDV and the reduction in LV ejection fraction. However, assessment of LVAR does not improve information provided by the early CMR.
引用
- Rodriguez-Palomares JF, Gavara J, Ferreira-González I, et al. Prognostic Value of Initial Left Ventricular Remodeling in Patients With Reperfused STEMI. JACC Cardiovasc Imaging. 2019. PMID: 31202752. doi:10.1016/j.jcmg.2019.02.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。